Clinical Trials Directory

Trials / Completed

CompletedNCT03105427

Leukocytes and Cardiovascular Perioperative Events-2

Assoziationen Von Leukozyten-Sub-Populationen im Blut kardiovaskulärer Risikopatienten Mit Der Inzidenz Perioperativer kardiovaskulärer Ereignisse

Status
Completed
Phase
Study type
Observational
Enrollment
233 (actual)
Sponsor
University Hospital Heidelberg · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The potential use of regulatory T cells as preoperative risk stratification tool is evaluated in order to improve clinical risk stratification and reduce perioperative morbidity and mortality.

Detailed description

Annually, there are more than 200 million surgeries worldwide. The POISE study revealed 5% of patients undergoing a non-cardiac surgery suffer perioperative myocardial infarcts going along with a perioperative mortality rate of about 11,6%. Possibilities to preoperatively identify patients at risk are limited and prophylactic interventions are not yet established or controversial. Selected leukocyte subpopulations have been demonstrated to be associated with higher risk for cardiovascular events. The aim of this study is to evaluate the potential use of regulatory T cells as preoperative risk stratification tool in order to improve clinical risk stratification and reduce perioperative morbidity and mortality. Therefore, high-risk cardiovascular patients scheduled for major non-cardiac surgery will be recruited. Blood will be drawn at predefined time points before surgery and up to three days postoperatively. Leukocytes will be analyzed by flow cytometry. During 30 day follow up adverse cardiovascular events will be recorded. ECGs will be recorded preoperatively and on post-OP day 3. High-sensitive cardiac Troponin T will be measured prior to the operation and on post-OP day one to three. The patient chart will be screened for cardiovascular events up to day 30. A telephone interview will be performed to detect cardiovascular events after discharge until post-OP day 30.

Conditions

Timeline

Start date
2017-04-10
Primary completion
2018-01-05
Completion
2018-01-05
First posted
2017-04-10
Last updated
2018-01-30

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03105427. Inclusion in this directory is not an endorsement.